Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.

BACKGROUND & AIMS Patients with Barrett's esophagus (BE) and high-grade dysplasia (HGD) or early neoplasia increasingly receive endoscopic mucosal resection and radiofrequency ablation (RFA) therapy. We analyzed data from a UK registry that follows the outcomes of patients with BE who have undergone RFA for neoplasia. METHODS We collected data on 335 patients with BE and neoplasia (72% with HGD, 24% with intramucosal cancer, 4% with low-grade dysplasia [mean age, 69 years; 81% male]), treated at 19 centers in the United Kingdom from July 2008 through August 2012. Mean length of BE segments was 5.8 cm (range, 1-20 cm). Patients' nodules were removed by endoscopic mucosal resection, and the patients then underwent RFA every 3 months until all areas of BE were ablated or cancer developed. Biopsies were collected 12 months after the first RFA; clearance of HGD, dysplasia, and BE were assessed. RESULTS HGD was cleared from 86% of patients, all dysplasia from 81%, and BE from 62% at the 12-month time point, after a mean of 2.5 (range, 2-6) RFA procedures. Complete reversal dysplasia was 15% less likely for every 1-cm increment in BE length (odds ratio = 1.156; SE = 0.048; 95% confidence interval: 1.07-1.26; P < .001). Endoscopic mucosal resection before RFA did not provide any benefit. Invasive cancer developed in 10 patients (3%) by the 12-month time point and disease had progressed in 17 patients (5.1%) after a median follow-up time of 19 months. Symptomatic strictures developed in 9% of patients and were treated by endoscopic dilatation. Nineteen months after therapy began, 94% of patients remained clear of dysplasia. CONCLUSIONS We analyzed data from a large series of patients in the United Kingdom who underwent RFA for BE-related neoplasia and found that by 12 months after treatment, dysplasia was cleared from 81%. Shorter segments of BE respond better to RFA; http://www.controlled-trials.com, number ISRCTN93069556.

[1]  J. Bergman,et al.  Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus , 2011, Endoscopy.

[2]  Gary Longton,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.

[3]  B. Overholt,et al.  Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. , 2007, Gastrointestinal endoscopy.

[4]  R. Playford.  New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus , 2006, Gut.

[5]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[6]  Hugh Barr,et al.  Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. , 2012, Gastroenterology.

[7]  A. Gavin,et al.  Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. , 2011, Journal of the National Cancer Institute.

[8]  P. Blount,et al.  Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. , 2000 .

[9]  Dennis M. Riehle,et al.  Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. , 2001, Gastroenterology.

[10]  M F Dixon,et al.  The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.

[11]  R. K. Pearson.  Radiofrequency Ablation in Barrett's Esophagus with Dysplasia , 2009 .

[12]  N. Soehendra,et al.  Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients , 2010, Gut.

[13]  P. I. Reed,et al.  The Changing Incidence of Oesophageal Cancer , 1993, Endoscopy.

[14]  C. Mosse,et al.  A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett’s oesophagus , 2013, Lasers in Medical Science.

[15]  Charles J. Lightdale,et al.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. , 2003, Gastrointestinal endoscopy.

[16]  N. Shaheen,et al.  Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. , 2012, Gastrointestinal endoscopy.

[17]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[18]  I. Penman,et al.  Endoscopic ablation of Barrett’s neoplasia with a new focal radiofrequency device: initial experience with the Halo60 , 2012, Endoscopy.

[19]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[20]  M. Stolte.  The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages , 2003, Virchows Archiv.

[21]  S. Dawsey,et al.  Tissue band ligation followed by snare resection (band and snare): a new technique for tissue acquisition in the esophagus. , 1996, Gastrointestinal endoscopy.

[22]  Hiroshi Mashimo,et al.  Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. , 2011, Gastroenterology.

[23]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[24]  L. Gossner,et al.  Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus , 2008, Gut.

[25]  C. D. Smith,et al.  Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device , 2005, Surgical Endoscopy And Other Interventional Techniques.

[26]  Outcome following surgery for squamous cell carcinoma of the oesophagus , 2009, ANZ journal of surgery.